QUIDEL POSTS 2.4% SALES GROWTH IN FY 1994 AS GAINS IN BRAND SALES OFFSET LOWER CONTRACT SALES; P-B MEDICAL BUSINESS SALES UP 6.2% TO $73.7 MIL. FOR QUARTER
This article was originally published in The Gray Sheet
Executive Summary
Quidel's quarterly and year-end results showed "modest" improvement as the rapid-diagnostics manufacturer continued to make progress in its effort to decrease dependence on sales to marketing partners, the company reported May 19.